NCT05535894Completed
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer
Endoscopic Ultrasound-guided Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
This study aims to evaluate the EUS-RFA in terms of efficacy for pain management and improvement in quality-of-life parameters for patients with advanced inoperable pancreatic cancer. The primary objectives of this study are to 1) evaluate the utility of EUS-RFA for pain control and improvement in quality-of-life parameters for patients with advanced pancreatic cancer; 2) to measure the reduction of analgesic medications' requirements in patients affected by inoperable pancreatic cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 19 (actual)
- First submitted
- 7 Sept 2022
- Start date
- 10 Aug 2022
- Primary completion date
- 30 Aug 2025
- Lead sponsor
- West Virginia University
- Diseases
- Pancreatic cancer
- NCT number
- NCT05535894
What you commit to
- Study type: Observational
- Participants enrolled: 19
- From 10 Aug 2022 to the primary completion date, 30 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Evidence of concurrent infection;
Other illness
- Surgically resectable pancreatic cancer;
- Abdominal pain with etiology other than pancreatic malignancy;
Lab values
- Patients with irreversible coagulopathy international normalized ratio \>1.5 or platelet count \<50,000/mm3),
Other
- Patients who are not willing to give informed consent or agree to participate in the study
- Patients with a preliminary diagnosis of adenocarcinoma are not possible established with intraprocedural at EUS-guided FNA.
Who the study is looking for
- Diagnosis of pancreatic cancer based on clinical, radiological, or pathological assessment;
- Referred for abdominal and/or back pain due to pancreatic cancer;
- No prior history of RFA;
- Cancer pain unresponsive to the WHO 3-step analgesic ladder;
- Willingness to consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shailendra Singh Coordinator of this site? Confirm its status | Morgantown | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.